Professor Ahmad Salehi, M.D., Ph.D.Stanford Medical School,Department of Psychiatry and Behavioral Sciences, and the Director of Translational Neuroscience Laboratory at VA Palo Alto Health Care System.
He obtained his M.D. from the SBMU in Tehran and his Ph.D. in Neurobiology from the Netherlands Institute for Brain Research in Amsterdam. During this period, he was chosen as the best Junior Neuroscientist in the field of Alzheimer’s disease at the University of Leiden, the Netherlands. Following postdoctoral training(s) at the Netherlands Institute for Brain Research and the Department of Neurology and Neurological Sciences at Stanford Medical School in Palo Alto, California, he worked as a Senior Scientist at Stanford Medical School for more than 8 years.
In 2010, he received the World Technology Award in the field of biotechnology from the World Technology Network in Manhattan, New York, for the use of multiple mouse models to identify genes involved in the pathogenesis of Down syndrome and Alzheimer’s disease. Salehi has numerous publications in peer-reviewed and high impact factor international journals of which seven have been featured on the cover.
Ahmad leads the Cognitive Research group at Silverberry, which focuses on reports such as memory performance, longevity, and more.
Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC. Increased App expression in a mouse model of Down’s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006 Jul 6;51(1):29-42. PMID: 16815330